RSC Holds 5th Conference on High Throughput Medicinal Chemistry
News May 04, 2009
The Royal Society of Chemistry’s (RSC) 5th High Throughput Medicinal Chemistry Conference takes place on 12th May 2009 at Alderley Park in Cheshire, UK.
The event will explore technology-enabled drug discovery as well as new synthetic technologies, with a particular focus on medicinal chemistry. As such, this conference will benefit a wide range of organic and medicinal chemists.
Since its conception, the RSC’s High Throughput Chemistry and New Technologies subject group has sought to highlight significant advances in the field, from the pharmaceutical, industrial and academic points of view.
Its 5th conference will focus specifically on: CH activation, Pd coupling, flow chemistry, fragment-based drug discovery and drug discovery in academia. This conference features line-up of speakers, including Greg Fu, MIT; Steven Woodhead, Astex Therapeutics; Rob Maleczka, Michigan State University; Paul Watts, University of Hull; and John G Cumming, Astra Zeneca.
Integrated Lead Discovery: An Evolving ToolboxNews
A new SLAS Discovery review article offers an informative guide to the established and emerging tools available for early drug discovery and screening, and provides illustrative scenarios demonstrating considerations that drive decisions on choice of lead discovery tactics.READ MORE
New Ovarian Cancer TargetNews
Researchers have found a prescription drug, Calcitriol, approved by the Food and Drug Administration for the treatment of calcium deficiency and kidney diseases, may increase the likelihood of surviving ovarian cancer. This new study opens a potential avenue for treating ovarian cancer. Since Calcitriol is an FDA-approved drug, no additional research is needed before the drug can advance to human clinical trials for ovarian cancer.READ MORE
Comments | 0 ADD COMMENT
27th International Conference on Nanomedicine and Nanomaterials
Oct 18 - Oct 19, 2018